harvoni
gilead sciences ireland uc - ledipasvir, sofosbuvir - hepatitis c, chronic - antivirals for systemic use - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4.2, 4.4 and 5.1).for hepatitis c virus (hcv) genotype-specific activity see sections 4.4 and 5.1.
epclusa 400mg/100mg tabletas recubiertas
gilead sciences, inc. - sofosbuvir - sofosbuvir....400mg / velpatasvir....100mg
harvoni 90mg/400mg tabletas recubiertas
gilead sciences, inc. - sofosbuvir - sofosbuvir....400.00 mg / ledipasvir....90.00 mg
buvir-c film-coated tablet
sofosbuvir - film-coated tablet - 400mg - sofosbuvir
harvoni film-coated tablet
gilead sciences, inc. 333 lakeside dr, foster city, ca 94404, usa - ledipasvir/sofosbuvir - film-coated tablet - 90 mg / 400mg - sofosbuvir and ledipasvir
hepcinat film-coated tablet
sofosbuvir - film-coated tablet - 400 mg - sofosbuvir
hepcvir coated tablet
sofosbuvir - coated tablet - 400 mg - sofosbuvir
hepcvir tablet
sofosbuvir - tablet - 400 mg - sofosbuvir
myhep dvir (daclatasvir and sofosbuvir film-coated tablet
mylan laboratories limited mylan laboratories limited. plot no.564/a/22, - daclatasvir and sofosbuvir film-coated tablets 60 - film-coated tablet - each film-coated tablet contains: daclatasvir - daclatasvir
myoview powder for injection
alatan teknologi sdn. bhd. - tetrofosmin -